Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist.
about
LP-211 is a brain penetrant selective agonist for the serotonin 5-HT(7) receptorSerotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disordersSB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in ratsTargeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date[(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptorsThe effect of SB-269970, a 5-HT(7) receptor antagonist, on 5-HT release from serotonergic terminals and cell bodiesCharacterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscleEffects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats.Evidence for the involvement of central 5-HT7 receptors in the micturition reflex in anaesthetized female ratsInactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition.Low-basicity 5-HT7 Receptor Agonists Synthesized Using the van Leusen Multicomponent ProtocolFunctional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT)The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.How (and why) the immune system makes us sleep.The 5-HT7 receptor and disorders of the nervous system: an overview.Pharmacological blockade of serotonin 5-HT₇ receptor reverses working memory deficits in rats by normalizing cortical glutamate neurotransmission5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders.Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives.5-HT(1A) and 5-HT(7) receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission.No hypothermic response to serotonin in 5-HT7 receptor knockout mice.Interplay between serotonin 5-HT1A and 5-HT7 receptors in depressive disorders.Therapeutic potential of serotonin antagonists in depressive disorders.Pharmacological characterization of the 5-HT receptors mediating contraction and relaxation of canine isolated proximal stomach smooth muscle.5-HT7 receptors mediate the inhibitory effect of 5-HT on peristalsis in the isolated guinea-pig ileumAutoradiographic distribution of 5-HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species.Effect of 5-HT7 receptor blockade on liver regeneration after 60-70% partial hepatectomy.The role of central 5-hydroxytryptamine (5-HT, serotonin) receptors in the control of micturition.The 5-HT(7) receptor in learning and memory.Expression of 5-HT7 receptor mRNA in the hamster brain: effect of aging and association with calbindin-D28K expression.5-HT7 receptor modulates GABAergic transmission in the rat dorsal raphe nucleus and controls cortical release of serotoninVagal control of the heart: central serotonergic (5-HT) mechanisms.Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient miceAssessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout modelsSynaptic transmission at functionally identified synapses in the enteric nervous system: roles for both ionotropic and metabotropic receptors.Hippocampal serotonin-1A receptor function in a mouse model of anxiety induced by long-term voluntary wheel running.Building a better antipsychotic: receptor targets for the treatment of multiple symptom dimensions of schizophrenia.Peripheral and spinal 5-HT receptors participate in cholestatic itch and antinociception induced by bile duct ligation in rats.Human 5-HT(4) and 5-HT(7) receptor splice variants: are they important?5-HT(7) receptor modulators: a medicinal chemistry survey of recent patent literature (2004 - 2009).The 5-HT7 receptor as a potential target for treating drug and alcohol abuse.
P2860
Q24602670-F10E7411-F713-4529-B041-9848F992BD21Q24632508-71D82B5F-162A-4300-AF1B-99916B57DA87Q24672651-B22D5D3E-EAA0-4E9E-9FA8-7E9E8B144F96Q28084125-7B5D771B-542F-4856-BE72-6C9104DB1ACCQ28344255-859E05B4-3CF5-4A20-8260-736A8ABEBFC2Q28361242-9D981541-471D-4470-902E-44C04BF960F7Q28363803-526AB68E-F132-4D13-9F4F-E0C56F3D01CAQ28533794-19F26091-6521-4EA2-AE32-AE32F56B2C55Q28574788-3DBEFD31-3895-40AA-8E83-CE1A1757A01EQ30491859-E96BA30F-1A46-43EF-A510-5CB471AE0B85Q33685407-7370BCFA-0BF1-45D6-96CA-7DD1DBD2348DQ33690754-58EC4C62-2A46-4166-A298-FC4DD587569CQ33706833-8D578FFC-EBF8-4376-AEC8-0078FD17B109Q33731135-602C1FF0-9CC2-49CF-B16D-9F4971244CEBQ33738349-121C144E-9E82-47B0-8A0F-3EF20298978EQ33942069-BCCF79BD-F530-483D-AF58-945EEBDB9F55Q34093279-A91E7A51-C82C-4035-9D27-7F100A267C47Q34172419-0D4EF6AB-7A10-4369-B754-69D28D1E5C5AQ34182072-DBE0BA9B-33D9-4CB0-945A-9016A08A0DB2Q34331037-8B78545C-8880-4755-88C1-34A992B1C1D0Q34425116-C3ED06A8-A79A-48F6-B572-0AC2566B9F83Q34581475-4B902012-C23D-48B2-B92D-7982F92FA148Q35044370-C07DD89F-0FA5-451E-AE8B-3D5705CE9D2AQ35045189-0FDD2C40-8583-40FD-B1C9-A71BB7B63CAEQ35046003-1DEF1610-98DA-4553-AB60-305FF934DB83Q35460340-3909EA29-88B4-4873-B79E-2E41F7592CAFQ35545729-56A66C9B-E846-4EB3-99BD-18361D05451DQ35848311-9777A352-C2D2-4707-9609-445903C1DAF8Q35878836-D59D3B13-5389-4594-A9FE-EE9A5A996125Q35964136-154EDB6F-0BA1-41E8-8C87-BDBE1BD711CCQ35986745-06959A72-7BC5-413D-9B13-ED089E93E913Q36975571-35489AA1-DDEC-4345-A59C-10280FDBA62FQ37206280-0C2D05CF-BFEA-4ABD-A2BB-C6249ABCDCCAQ37211805-592B8745-A9DD-4185-9062-0C09AED0A8CFQ37276931-C113E7C0-4627-4A3D-B34A-9BEEC52CD8D1Q37358657-1D478F5A-2219-48AC-A0F8-DB38AD746E77Q37399902-59037D0C-A3D4-4D54-9C7F-E24297A0F318Q37420451-A128CDD1-28BA-4B0F-B37E-CDCC96F186CDQ37754465-77C00B58-7F27-4440-B0B0-BB7594868355Q38335136-CE618686-C0E8-406E-93C8-BF5FCDF482B4
P2860
Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist.
@en
type
label
Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist.
@en
prefLabel
Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist.
@en
P2093
P2860
P356
P1476
Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist.
@en
P2093
A D Medhurst
D N Middlemiss
D R Thomas
P2860
P304
P356
10.1038/SJ.BJP.0703357
P407
P577
2000-06-01T00:00:00Z